| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 6 | |
| #2 | WIPO (World Intellectual Property Organization) | 6 | |
| #3 | Canada | 3 | |
| #4 | EPO (European Patent Office) | 3 | |
| #5 | Japan | 2 | |
| #6 | Argentina | 1 | |
| #7 | Australia | 1 | |
| #8 | Hong Kong | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Agriculture |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Microorganisms | |
| #4 | Peptides | |
| #5 | Animal care | |
| #6 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Guberski Dennis L | 17 |
| #2 | Yang Kejian | 16 |
| #3 | Whalen Barbara J | 6 |
| #4 | Kislauskis Edward H | 6 |
| #5 | Kislauskis Edward | 5 |
| #6 | Prescott Albert G | 2 |
| #7 | Guberski Dennis | 2 |
| #8 | Tirabassi Rebecca S | 2 |
| #9 | Flanagan Joan F | 2 |
| #10 | Yang Kenjian | 1 |
| Publication | Filing date | Title |
|---|---|---|
| CA2897398A1 | Use of vaccines for the treatment of herpes simplex virus type 2 infections | |
| CA2792679A1 | A novel mucosal vaccination approach for herpes simplex virus type-2 | |
| WO2006050116A1 | Methods of cancer treatment/prevention using cancer cell-specific surface antigens | |
| US2006179499A1 | Non-human animal models for diabetic complications and their uses | |
| CA2552004A1 | Methods for tailoring the immune response to an antigen or immunogen | |
| AU2003256596A1 | Extended release analgesic for pain control | |
| US6939538B2 | Extended release analgesic for pain control |